Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients

NCT03931928 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

356

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
DCIS

Interventions

DRUG: (Z)-Endoxifen supplementation according to genotype
DRUG: (Z)-Endoxifen supplementation according to plasma levels

Sponsor

Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)